Adaptimmune Therapeutics plc (ADAP)
NASDAQ: ADAP · Real-Time Price · USD
0.560
-0.020 (-3.45%)
At close: Feb 21, 2025, 4:00 PM
0.562
+0.002 (0.43%)
After-hours: Feb 21, 2025, 6:21 PM EST
Adaptimmune Therapeutics Market Cap
Adaptimmune Therapeutics has a market cap or net worth of $143.17 million as of February 21, 2025. Its market cap has decreased by -52.61% in one year.
Market Cap
143.17M
Enterprise Value
31.57M
1-Year Change
-52.61%
Ranking
Category
Stock Price
$0.56
Market Cap Chart
Since March 31, 2016, Adaptimmune Therapeutics's market cap has decreased from $575.60M to $143.17M, a decrease of -75.13%. That is a compound annual growth rate of -14.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 143.10M | 3.77% |
| Dec 31, 2024 | 137.90M | -23.43% |
| Dec 29, 2023 | 180.10M | -24.71% |
| Dec 30, 2022 | 239.20M | -59.17% |
| Dec 31, 2021 | 585.90M | -29.78% |
| Dec 31, 2020 | 834.40M | 561.17% |
| Dec 31, 2019 | 126.20M | -79.02% |
| Dec 31, 2018 | 601.40M | -3.93% |
| Dec 29, 2017 | 626.00M | 118.35% |
| Dec 30, 2016 | 286.70M | -50.19% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.85B |
| UnitedHealth Group | 463.47B |
| Johnson & Johnson | 383.77B |
| Novo Nordisk | 370.06B |
| AbbVie | 352.03B |
| Abbott Laboratories | 230.34B |
| AstraZeneca | 227.07B |
| Merck & Co. | 219.55B |